Русский
Unifactorial prediction of the risks of development and progression of cardiovascular diseases
DOI: https://dx.doi.org/10.18565/pharmateca.2024.4.48-53
Derbeneva S.A., Pogozheva A.V., Shmeleva S.V., Sabanchieva Zh.Kh.
1) Federal Research Center for Nutrition and Biotechnology, Moscow, Russia; 2) Moscow State University of Technology and Management n.a. K.G. Razumovsky, Moscow, Russia; 3) Kabardino-Balkarian State University n.a. Kh.M. Berbekov, Nalchik, Russia
Background. Prevention of cardiovascular diseases requires early identification of people at high risk so that effective dietary, lifestyle, or drug interventions can be implemented.
Objective. Evaluation of the clinical, instrumental and laboratory parameters as markers of the development and progression of cardiovascular diseases (CVDs).
Methods. Assessment of actual nutrition and physical activity at home, anthropometric studies, assessment of body composition, study of energy metabolism with determination of daily nitrogen excretion, study of indicators of resting metabolism and macronutrient metabolism. Laboratory studies included the general blood test, clinical urinalysis, analysis of biochemical markers of lipid, protein and carbohydrate metabolism, parameters of the functional activity of the hepatobiliary system, blood coagulation system, hormonal profile indicators, electrolyte metabolism, vitamin status, lipid peroxidation products and enzymes of the antioxidant protection system.
Results. In 956 patients with cardiovascular diseases, specific factors predicting the development of coronary artery disease (CAD) were identified: silent myocardial ischemia, post-infarction cardiosclerosis, condition after surgical treatment, angina pectoris 1 functional class. Prediction of the risk of developing a particular clinical event from specific quantitative or binary indicators of the metabolic status of patients was carried out using the Pearson Chi-square test.
Conclusion. In one clinical case of CAD, biomarkers of metabolic status were identified as key, in another case – parameters of the clinical course of atherosclerotic disease, in the third and fourth – their combination. Taking into account the presence of these factors, it is possible to carry out measures for their adequate and timely correction, thereby preventing the development and progression of these nosological forms.
Objective. Evaluation of the clinical, instrumental and laboratory parameters as markers of the development and progression of cardiovascular diseases (CVDs).
Methods. Assessment of actual nutrition and physical activity at home, anthropometric studies, assessment of body composition, study of energy metabolism with determination of daily nitrogen excretion, study of indicators of resting metabolism and macronutrient metabolism. Laboratory studies included the general blood test, clinical urinalysis, analysis of biochemical markers of lipid, protein and carbohydrate metabolism, parameters of the functional activity of the hepatobiliary system, blood coagulation system, hormonal profile indicators, electrolyte metabolism, vitamin status, lipid peroxidation products and enzymes of the antioxidant protection system.
Results. In 956 patients with cardiovascular diseases, specific factors predicting the development of coronary artery disease (CAD) were identified: silent myocardial ischemia, post-infarction cardiosclerosis, condition after surgical treatment, angina pectoris 1 functional class. Prediction of the risk of developing a particular clinical event from specific quantitative or binary indicators of the metabolic status of patients was carried out using the Pearson Chi-square test.
Conclusion. In one clinical case of CAD, biomarkers of metabolic status were identified as key, in another case – parameters of the clinical course of atherosclerotic disease, in the third and fourth – their combination. Taking into account the presence of these factors, it is possible to carry out measures for their adequate and timely correction, thereby preventing the development and progression of these nosological forms.
About the Autors
Corresponding author: Svetlana V. Shmeleva, Dr. Sci. (Med.), Professor, Moscow University of Technology and Management n.a. K.G. Razumovsky, Moscow, Russia; 89151479832@mail.ru
Similar Articles
